Maksim M. SHMAROV,Raisa I. YAKUBOVSKAYA,Rustam R. ATAULLAKHANOV
申请号：
US14459975
公开号：
US20140357550A1
申请日:
2014.08.14
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A pharmaceutical composition for treatment of acute toxic conditions relates to the field of medicine, particularly to nanotechnology and toxicology, and can be used for prophylaxis and therapy of various etiologies of toxic states, including the acute ones. The claimed pharmaceutical composition for treatment of acute toxic conditions contains protein—the human lactoferrin—and further comprises of non-replicating nanoparticles with inset of human lactoferrin gene and formulating buffer. The dose of the claimed pharmaceutical composition is 3 ml. The dose of the claimed pharmaceutical composition comprises: human lactoferrin—from 50 to 100 mg non-replicating nanoparticles—7×1011 virus particle (v.p.) formulating buffer—rest, ml. At the same time, the donor human milk lactoferrin or any human lactoferrin is used as the human lactoferrin.
